Cognitive changes showed a high expression of RALYL accompanied by an apparent slow cognitive decline in the duplicate MMSE tests (first AD diagnostic MMSE and last valid MMSE) during follow-up (multiple t tests, adjusted p = 0.019) (Fig. 6d). Here, RALYL is linked to Mental deterioration.